Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04621877 · ClinicalTrials.gov registry record · NA

Lay-Delivered Behavioral Activation in Senior Centers

A NA study of Depression, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
288
Enrollment target
20
Study locations

NCT04621877: Recruiting NA study of Depression, sponsored by University of Washington.

NCT04621877 is a NA study of Depression that is actively recruiting participants, run by University of Washington. The registered enrollment target is 288 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04621877, a NA study of Depression, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
288 participants
Enrollment target
20
Study locations

Study Summary

In response to large numbers of senior center clients who suffer untreated depression and the dearth of geriatric mental health providers, the investigators have simplified Behavioral Activation to be delivered by lay volunteers ("Do More, Feel Better"; DMFB). The focus of Behavioral Activation is to guide clients to reengage in daily pleasant and rewarding activities, and reduce depressive symptoms. If the investigators can show that the lay delivery model has positive impact in comparison to MSW-delivered Behavioral Activation, the investigators will have identified an effective intervention that can be used by a large untapped workforce of older adult volunteers across the nation.

Primary Outcome

The HAM-D will be used as measure of depressive symptom severity. The HAM-D is a clinically administered measure and has been validated in a variety of psychiatric populations.

Conditions Studied

Interventions

  • BEHAVIORAL Volunteer-delivered Behavioral Activation
  • BEHAVIORAL Master's level clinician-delivered Behavioral Activation

Study Locations (20)

New York

  • Diana Jones Senior Center - Brooklyn
  • Edie Windsor SAGE Center - New York
  • Hudson Guild Senior Center - New York
  • Lincoln Square Senior Center - New York
  • Goddard Riverside Community Center and NORC - New York
  • Carver Senior Center - New York
  • Dyckman Senior Center - New York
  • Stanley M. Isaacs Neighborhood Center - New York
  • SAGE Center Brooklyn at Stonewall House - New York

Florida

  • Brandon Senior Center - Brandon
  • Gardenville Dining & Activity Center - Gibsonton
  • Ruskin Senior Center - Ruskin
  • JL Young Apartments (Senior Housing) - Tampa
  • Oaks at Riverview Senior Center - Tampa
  • Jewish Towers Senior Housing - Tampa
  • Town 'n Country Senior Center - Tampa
  • Progress Village Senior Center - Tampa

Washington

  • Enumclaw Senior Center - Enumclaw
  • Greenwood Senior Center - Seattle
  • West Seattle Senior Center - Seattle

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2021-01-27
Est. Completion 2025-12-01
Phase NA
University of Washington

1,048 total trials

What NCT04621877 shows while recruiting

NCT04621877 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Volunteer-delivered Behavioral Activation is the first listed.

NCT04621877 names 20 study sites across 3 states, led by New York, Florida, Washington.

Frequently Asked Questions

What is clinical trial NCT04621877 about?

NCT04621877 is a clinical study titled "Lay-Delivered Behavioral Activation in Senior Centers". In response to large numbers of senior center clients who suffer untreated depression and the dearth of geriatric mental health providers, the investigators have simplified Behavioral Activation to be delivered by lay volunteers ("Do More, Feel Better"; DMFB). The focus of Behavioral Activation is t...

What is the current status of trial NCT04621877?

This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2021-01-27. Estimated completion is 2025-12-01.

What conditions does trial NCT04621877 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT04621877?

The interventions under investigation include: Volunteer-delivered Behavioral Activation (BEHAVIORAL), Master's level clinician-delivered Behavioral Activation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04621877?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04621877 being conducted?

This trial has 20 study locations across Florida, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04621877's enrollment target sits among peer trials

288 156th of 679 higher than 524 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02098265 · 288 participants · NA

    A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

  • NCT03741777 · 288 participants · NA

    Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume

  • NCT03937635 · 288 participants · Phase 3

    Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • NCT05150704 · 288 participants · Phase 3

    MYTHS - MYocarditis THerapy With Steroids

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04621877, the US trial registry maintained by the National Library of Medicine. NCT04621877 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.